Inicio › Afecciones posteriores al COVID-19 (COVID-19 persistente) › Texas › Houston
Ensayos clínicos de Afecciones posteriores al COVID-19 (COVID-19 persistente) en Houston, TX
13 estudios para Afecciones posteriores al COVID-19 (COVID-19 persistente) buscan participantes en centros de Houston y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)
ReclutandoFase 3
- Houston Methodist Hospital ( Site 3800), Houston
- MD Anderson ( Site 3843), Houston
A Study of COVID-19 Vaccine(s) in Children and Adults
ReclutandoFase 3Se aceptan voluntarios sanos
- DM Clinical Research-Cyfair, Houston
A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
ReclutandoFase 3
- Cockrell Center for Advanced Therapeutics, Houston
- Houston Methodist - Transplant Center, Houston
- Houston Methodist Hospital, Houston
- y 4 más
A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
ReclutandoFase 3
- Memorial Hermann Hospital TMC, Houston
- The University of Texas Health Science Center at Houston, Houston
- UT Physicians, Houston
- y 4 más
The Impact of COVID-19 on Pulmonary Procedures
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
- M D Anderson Cancer Center, Houston
Assessment of the Psychosocial Impact of the COVID-19 Pandemic on the MD Anderson Cancer Center Workforce
ReclutandoEstudio observacional
- M D Anderson Cancer Center, Houston
Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study
ReclutandoFase 3
- Baylor College of Medicine, Houston
- MD Anderson, Houston
The Effect of COVID-19 Pandemic on Adolescent and Young Adult Cancer Patients and Survivors
ReclutandoEstudio observacional
- M D Anderson Cancer Center, Houston
Impact of COVID-19 Pandemic on Out-of-Pocket Costs, Lost Wages, and Unemployment in Patients With Breast Cancer Undergoing Breast Surgery
ReclutandoEstudio observacional
- M D Anderson Cancer Center, Houston
Well-Being and Health-Related Quality of Life in Melanoma Patients During COVID-19 Pandemic
ReclutandoEstudio observacional
- M D Anderson Cancer Center, Houston
Vale+Tú Salud: Corner-Based Trial to Test a Latino Day Laborer Program Adapted to Prevent COVID-19
Reclutando
- The University of Texas Health Science Center at Houston, Houston
EPIC-Peds: A Study to Learn About the Study Medicine Called PF-07321332 (Nirmatrelvir)/Ritonavir in Patients Under 18 Years of Age With COVID-19 That Are Not Hospitalized But Are at Risk for Severe Disease
ReclutandoFase 3
- Texas Children's Hospital, Houston
Clazakizumab vs. Placebo - COVID-19 Infection
ReclutandoFase 2
- Houston Methodist Hospital, Houston
Más información sobre Afecciones posteriores al COVID-19 (COVID-19 persistente) en MedlinePlus
Ensayos de Afecciones posteriores al COVID-19 (COVID-19 persistente) en otras ciudades
- New York City, NY15 estudios
- Boston, MA13 estudios
- Baltimore, MD12 estudios
- Chicago, IL11 estudios
- Washington, DC10 estudios
- San Francisco, CA8 estudios
- Durham, NC8 estudios
- Atlanta, GA8 estudios
- San Diego, CA7 estudios
- Los Angeles, CA6 estudios
- Pittsburgh, PA6 estudios
- Hialeah, FL6 estudios
Otros estudios en Houston
- Cáncer de pulmón de células no pequeñas145 estudios
- Cáncer de seno126 estudios
- Cáncer (todos los tipos)121 estudios
- Cáncer metastásico104 estudios
- Cáncer del colon y del recto102 estudios
- Cáncer de ovario89 estudios
- Leucemia mielógena aguda85 estudios
- Cáncer de pulmón78 estudios
- Cáncer de próstata76 estudios
- Cáncer de endometrio68 estudios
- Cáncer de páncreas61 estudios
- Melanoma59 estudios
De ClinicalTrials.gov, datos obtenidos el 6 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.